ATE259235T1 - Zubereitung enthaltend glykane übereinstimmend mit transferrin glykaner als aktives prinzip für die induktion der immuntoleranz gegen antigene - Google Patents

Zubereitung enthaltend glykane übereinstimmend mit transferrin glykaner als aktives prinzip für die induktion der immuntoleranz gegen antigene

Info

Publication number
ATE259235T1
ATE259235T1 AT95401729T AT95401729T ATE259235T1 AT E259235 T1 ATE259235 T1 AT E259235T1 AT 95401729 T AT95401729 T AT 95401729T AT 95401729 T AT95401729 T AT 95401729T AT E259235 T1 ATE259235 T1 AT E259235T1
Authority
AT
Austria
Prior art keywords
glycans
induction
active principle
transferrin
host
Prior art date
Application number
AT95401729T
Other languages
English (en)
Inventor
Walter Pierpaoli
Gonzague S Kistler
Original Assignee
Cell Eng Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Eng Ag filed Critical Cell Eng Ag
Application granted granted Critical
Publication of ATE259235T1 publication Critical patent/ATE259235T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT95401729T 1995-07-20 1995-07-20 Zubereitung enthaltend glykane übereinstimmend mit transferrin glykaner als aktives prinzip für die induktion der immuntoleranz gegen antigene ATE259235T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95401729A EP0754459B1 (de) 1995-07-20 1995-07-20 Zubereitung enthaltend Glykane übereinstimmend mit Transferrin Glykaner als aktives Prinzip für die Induktion der Immuntoleranz gegen Antigene

Publications (1)

Publication Number Publication Date
ATE259235T1 true ATE259235T1 (de) 2004-02-15

Family

ID=8221508

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95401729T ATE259235T1 (de) 1995-07-20 1995-07-20 Zubereitung enthaltend glykane übereinstimmend mit transferrin glykaner als aktives prinzip für die induktion der immuntoleranz gegen antigene

Country Status (8)

Country Link
US (1) US6299878B1 (de)
EP (1) EP0754459B1 (de)
JP (1) JPH11511186A (de)
AT (1) ATE259235T1 (de)
AU (1) AU715022B2 (de)
CA (1) CA2226879A1 (de)
DE (1) DE69532557T2 (de)
WO (1) WO1997003680A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997047308A1 (en) * 1996-06-11 1997-12-18 Cellena Ag Eutrophic drug compositions based on transferrin glycans
CA2876779A1 (en) * 2000-05-12 2001-11-22 Genzyme Corporation Modulators of tnf-.alpha. signaling
DE10132308A1 (de) * 2001-07-06 2003-01-30 Aventis Behring Gmbh Kombinationspräparat zur Therapie von immunologischen Erkrankungen
WO2003086272A2 (en) * 2002-04-16 2003-10-23 Kamada Ltd. Ultrapure transferrin for pharmaceutical compositions
JP4928079B2 (ja) * 2002-11-21 2012-05-09 ジェンザイム・コーポレーション 慢性組織移植片拒絶を阻害するためのジアミド誘導体の使用
WO2004047826A1 (en) * 2002-11-21 2004-06-10 Genzyme Corporation Combination of diamide derivatives and immunosuppressive agents for induction of immune tolerance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0426924A1 (de) * 1989-11-09 1991-05-15 Cellena (Cell Engineering) A.G. Herstellung von Verbindungen mit Metalltransporteigenschaften zur Erleichterung der Transplantation von gewebeunverträglichem Knochenmark und zur Kontrolle der Immunreaktionen im Empfänger

Also Published As

Publication number Publication date
DE69532557D1 (de) 2004-03-18
WO1997003680A1 (en) 1997-02-06
EP0754459A1 (de) 1997-01-22
EP0754459B1 (de) 2004-02-11
JPH11511186A (ja) 1999-09-28
US6299878B1 (en) 2001-10-09
AU6733896A (en) 1997-02-18
AU715022B2 (en) 2000-01-13
CA2226879A1 (en) 1997-02-06
DE69532557T2 (de) 2004-12-23

Similar Documents

Publication Publication Date Title
Gregory et al. How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow
Galili Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans
Oursler et al. Identification of osteoclast-specific monoclonal antibodies.
Flores et al. Periodontal ligament cell sheet promotes periodontal regeneration in athymic rats
Paebst et al. Comparative immunophenotyping of equine multipotent mesenchymal stromal cells: an approach toward a standardized definition
Katz et al. The role of Langerhans cells in antigen presentation
Enzmann et al. Stem cells as tools in regenerative therapy for retinal degeneration
Labat-Robert et al. Fibronectin-like protein in Porifera: its role in cell aggregation.
US8440460B2 (en) Methods for transdifferentiating cells
DE69431107T2 (de) Die erzeugung von toleranz gegen fremdtransplantate durch tolerogenese mit hilfe von ersatzlebewesen
CA2284079A1 (en) Immunotoxins and methods of inducing immune tolerance
US20210145889A1 (en) Methods, compositions, and implantable elements comprising stem cells
BR9612821A (pt) Métodos para a prevenção de rejeição de enxerto em transplante e para a produção de uma célula de hospedeiro para terapia genética universal
Sheikh et al. Alpha-gal-independent dual recognition and activation of xenogeneic endothelial cells and human naive natural killer cells1
ATE259235T1 (de) Zubereitung enthaltend glykane übereinstimmend mit transferrin glykaner als aktives prinzip für die induktion der immuntoleranz gegen antigene
James et al. HY peptides modulate transplantation responses to skin allografts
Charron et al. Immunogenicity and allogenicity: a challenge of stem cell therapy
Melgar-Lesmes et al. Implantation of healthy matrix-embedded endothelial cells rescues dysfunctional endothelium and ischaemic tissue in liver engraftment
Xu et al. Interaction between mesenchymal stem cells and immune cells during bone injury repair
DE69333547D1 (de) Therapeutische anwendungen von chimänischer organogenese
DE69638145D1 (de) Verfahren zur herbeiführung einer immuntoleranz mit hilfe von immuntoxinen
EP0790834B1 (de) Zusammensetzungen die gemischte transferrine als wirkstoff für induktion von immunotoleranz gegen antigen enthalten
Brevig et al. XENOTRANSPLANTATION FOR BRAIN REPAIR: Reduction of Porcine Donor Tissue Immunogenicity by Treatment with Anti-Gal Antibodies and Complement: 1
Harness et al. MSC therapy in livestock models
Plendl et al. Primitive endothelial cell lines from the porcine embryonic yolk sac

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties